quinoxalines has been researched along with Hyperemia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, CY; Lee, JS | 1 |
| Aihara, M; Isobe, T; Kanazawa, M; Koizumi, N; Kojima, S; Minami, H; Suganami, H; Tanihara, H; Yamamoto, T | 1 |
| Aufderheide, A; Avila, MR; Brinton, JP; Durrie, DS; Pasquali, TA; Stahl, ED | 1 |
| Delgado-Ortega, L; Díaz-Cerezo, S; Pinazo-Durán, MD; Soto-Alvarez, J; Vinuesa-Silva, I; Vinuesa-Silva, JM | 1 |
| Batoosingh, A; Felix, C; Mundorf, T; Whitcup, S; Williams, R | 1 |
| Chen, G; Ebner, TJ; Iadecola, C; Yang, G | 1 |
| Gross, RL; Orengo-Nania, S; Williams, GC | 1 |
2 review(s) available for quinoxalines and Hyperemia
| Article | Year |
|---|---|
Brimonidine tartrate ophthalmic solution 0.025% for redness relief: an overview of safety and efficacy.
Topics: Adrenergic alpha-Agonists; Brimonidine Tartrate; Erythema; Humans; Hyperemia; Nasal Decongestants; Ophthalmic Solutions; Quality of Life; Quinoxalines; Receptors, Adrenergic | 2022 |
[Development of conjunctival hyperemia with the use of a fixed combination of latanoprost/timolol: systematic review and meta-analysis of clinical trials].
Topics: Aged; Brimonidine Tartrate; Clinical Trials as Topic; Cloprostenol; Conjunctival Diseases; Cross-Over Studies; Drug Combinations; Drug Therapy, Combination; Glaucoma; Humans; Hyperemia; Latanoprost; Middle Aged; Ocular Hypertension; Odds Ratio; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiazines; Timolol; Travoprost | 2009 |
3 trial(s) available for quinoxalines and Hyperemia
| Article | Year |
|---|---|
Crossover Randomized Study of Pharmacologic Effects of Ripasudil-Brimonidine Fixed-Dose Combination Versus Ripasudil or Brimonidine.
Topics: Adult; Antihypertensive Agents; Brimonidine Tartrate; Endothelial Cells; Glaucoma, Open-Angle; Humans; Hyperemia; Intraocular Pressure; Male; Ocular Hypertension; Ophthalmic Solutions; Prospective Studies; Quinoxalines | 2023 |
Dilute brimonidine to improve patient comfort and subconjunctival hemorrhage after LASIK.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Adult; Brimonidine Tartrate; Conjunctival Diseases; Double-Blind Method; Drug Therapy, Combination; Eye Hemorrhage; Female; Histamine H1 Antagonists; Humans; Hyperemia; Keratomileusis, Laser In Situ; Lasers, Excimer; Male; Middle Aged; Naphazoline; Patient Satisfaction; Pheniramine; Postoperative Complications; Prospective Studies; Quinoxalines; Refraction, Ocular; Refractive Surgical Procedures; Visual Acuity; Young Adult | 2013 |
A 3-month comparison of efficacy and safety of brimonidine-purite 0.15% and brimonidine 0.2% in patients with glaucoma or ocular hypertension.
Topics: Adrenergic alpha-Agonists; Brimonidine Tartrate; Conjunctiva; Conjunctivitis, Allergic; Dose-Response Relationship, Drug; Double-Blind Method; Glaucoma; Humans; Hyperemia; Intraocular Pressure; Ocular Hypertension; Quinoxalines; Severity of Illness Index | 2003 |
2 other study(ies) available for quinoxalines and Hyperemia
| Article | Year |
|---|---|
Nitric oxide is the predominant mediator of cerebellar hyperemia during somatosensory activation in rats.
Topics: Animals; Blood Pressure; Brain Stem; Carbon Dioxide; Cerebellar Cortex; Cerebellum; Cerebrovascular Circulation; Electric Stimulation; Enzyme Inhibitors; Glucose; Hyperemia; Indazoles; Laser-Doppler Flowmetry; Male; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Oxadiazoles; Quinoxalines; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Somatosensory Cortex; Tetrodotoxin | 1999 |
Incidence of brimonidine allergy in patients previously allergic to apraclonidine.
Topics: Adolescent; Adrenergic alpha-Agonists; Adult; Aged; Aged, 80 and over; Brimonidine Tartrate; Clonidine; Conjunctivitis; Cross Reactions; Dermatitis, Allergic Contact; Drug Hypersensitivity; Female; Glaucoma; Humans; Hyperemia; Incidence; Male; Middle Aged; Quinoxalines; Retrospective Studies; Risk Factors | 2000 |